«Zygomycosis

Below is an extended Zygomycosis patents listing. Click here to return to the Zygomycosis main in depth entry.

Patents :
US Patent No.	Title
5702698	Methods of use of IL-1.alpha.
6623941	Nucleic acids encoding human tumor necrosis factor TR20
6627408	Antifungal assay
6635482	Monoclonal antibodies to membrane neutrokine-.alpha.
6716625	Histidine kinases of Aspergillus and other fungal species, related compositions, and methods of use
6730495	Methods for the identification of antimicrobial compounds
6743598	Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
6743897	Aspergillus fumigatus profilin
6774104	Stabilized pharmaceutical composition in lyophilized form
6812327	Neutrokine-alpha polypeptides
6849719	Antibody to an IL-17 receptor like protein
6562579	Diagnostic methods using antibodies to Neutrokine-alpha
6541224	Tumor necrosis factor delta polypeptides
6468760	Antifungal assay
5744453	Polyamine conjugates for treatment of infection
5847098	DNA encoding interleukin IL-1.beta. mutant
5939306	Osmosensing histidine kinases
6017906	Polyamine conjugates for treatment of infection
6107465	IL-1.beta. and derivatives thereof and drugs
6284480	Antifungal assay
6403372	Aspergillus fumigatus profilin
6403770	Antibodies to neutrokine-alpha
6406867	Antibody to human endokine alpha and methods of use
6458930	Aspergillus fumigatus cofilin
6861227	Antibodies to cytokine receptor common gamma chain like
6875740	Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens
7189820	Antibodies against tumor necrosis factor delta (APRIL)
7217788	Human tumor necrosis factor delta polypeptides
7220840	Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7312051	Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
7351739	Bioactive compounds and methods of uses thereof
7354584	Recombinant IL-9 antibodies
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7375081	Therapeutic combination of a pneumocandin derivative and an antifungal agent
7393534	Compositions and methods for immunotherapy of cancer and infectious diseases
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7164004	Human tumor necrosis factor TR20 and methods based thereon
7138501	Antibodies that immunospecifically bind BLyS
7112565	Stabilized pharmaceutical composition in lyophilized form
6881401	Methods of treatment of immune system related disorders using Neutrokine-alpha
6884774	Cyclic hexapeptide derivatives
6884868	Cyclic hexapeptides having antibiotic activity
6905840	Double motor mutant assay for antifungal agents
6969519	Methods of using an agonistic antibody human tumor necrosis factor receptor (TR17)
7001718	Method of inhibiting pathogenicity of infectious agents
7012134	Dendritic enriched secreted lymphocyte activation molecule
7034113	Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
7078027	Human endokine alpha
7112410	Human tumor necrosis factor TR21 and methods based thereon
7429646	Antibodies to human tumor necrosis factor receptor-like 2

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.